Tuesday, June 17, 2014

Pharmacy Board of Australia Seeking Comments on Compounding Guidelines

Compounding of medicines

Public consultation is now open on the Guidelines on compounding of medicines for pharmacists. You can access the consultation paper and response form on the Current Consultations page on the Board’s website.
The guidelines will provide guidance to pharmacists who extemporaneously prepare medicines, including ‘simple compounding’ and ‘complex compounding’ (as defined in the draft guidelines).
Consultation on the guidelines will close on 30 June 2014 and the community, stakeholders, pharmacists and other health practitioners are welcome to make a submission.
The Board is also conducting a separate consultation on a draft Professional practice profile for pharmacists undertaking complex compounding (practice profile). The practice profile is referenced in the compounding guidelines. The practice profile is a tool intended to assist pharmacists to understand the performance expected of them when undertaking complex compounding.
The consultation paper is also published on the Board’s Current Consultations page. Consultation on the practice profile will close on 30 June 2014.

Registration standards and related guidelines

The Board is consulting on a review of the following registration standards:
  • Professional indemnity insurance
  • Continuing professional development (and associated guidelines)
  • Recency of practice
  • Supervised practice arrangements, and
  • Examinations for eligibility for general registration.
The Board began its review of these documents within three years of implementation of the current registration standards and related guidelines in 2010. The consultation process to date has included research and preliminary consultation with stakeholders.
You can access the public consultation paper and response form on the Current Consultations page on the Board’s website. Consultation will close on 30 June 2014 and the community, stakeholders, pharmacists and other health practitioners are welcome to make a submission.
quoted from here

No comments: